The Absence of Recent Systemic Therapy can be a Significant Risk Factor for Nemolizumab-associated Cutaneous Adverse Events in Patients with Prurigo Nodularis: A Single-centre Retrospective Study

Bibliographic Details
Published in:	Acta Dermato-Venereologica
Main Authors:	Yoshihito Mima, Masako Yamamoto, Ken Iozumi
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2025-10-01
Subjects:	Prurigo nodularis Nemolizumab systemic therapy cutaneous adverse events Th2
Online Access:	https://medicaljournalssweden.se/actadv/article/view/44310

Internet